technetium has been researched along with Congestive Ophthalmopathy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa da Fonseca, LM; de Lacerda, AM; de Souza, SAL; Gutfilen, B; Lobo Lopes, FPP; Teixeira, PFDS; Tonomura, E; Vaisman, M | 1 |
da Fonseca, LM; de Souza, SA; dos Santos Teixeira, Pde F; Gutfilen, B; Lopes, FP; Rebelo Pinto, Edos S; Vaisman, M | 1 |
da Fonseca, LM; de Souza, SA; Dos Santos Teixeira, Pde F; Gutfilen, B; Lopes, FP; Rebelo Pinho, Edos S; Vaisman, M | 1 |
1 trial(s) available for technetium and Congestive Ophthalmopathy
Article | Year |
---|---|
A pilot study evaluating 99mTc-anti-TNF-alpha scintigraphy in graves' ophtalmopathy patients with different clinical activity score.
Topics: Adult; Antibodies; Eye; Graves Ophthalmopathy; Humans; Inflammation; Middle Aged; Orbit; Pilot Projects; Predictive Value of Tests; Research Design; Sensitivity and Specificity; Severity of Illness Index; Technetium; Tomography, Emission-Computed, Single-Photon; Tumor Necrosis Factor-alpha | 2013 |
2 other study(ies) available for technetium and Congestive Ophthalmopathy
Article | Year |
---|---|
Technetium-99m-anti-tumour necrosis factor alpha scintigraphy as promising predictor of response to corticotherapy in chronic active Graves' ophthalmopathy.
Topics: Adalimumab; Adrenal Cortex Hormones; Female; Graves Ophthalmopathy; Humans; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Remission Induction; Reproducibility of Results; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Tumor Necrosis Factor-alpha | 2019 |
99mTc-Anti-TNF-α scintigraphy: a new perspective within different methods in the diagnostic approach of active Graves ophthalmopathy.
Topics: Antibodies, Monoclonal; Graves Ophthalmopathy; Humans; Magnetic Resonance Imaging; Octreotide; Organotechnetium Compounds; Technetium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha | 2012 |